Bayer hemophilia treatment wins thumbs-up from EU panel
Bayer AG's long-acting treatment for hemophilia A has won a recommendation from a European Medicines Agency (EMA) panel for the treatment of the rare genetic disorder in which blood does not clot easily.
from Reuters: Health News https://reut.rs/2xC2fQZ
http://bit.ly/2zwRqiM